Global Presence & Distribution

Mefloquine Tablets USP 250mg by Taj Pharma - Trusted presence across global markets with comprehensive regulatory compliance and distribution networks.

Export Countries & Markets

Africa

East Africa
  • Kenya
  • Tanzania
  • Uganda
  • Rwanda
  • Burundi
  • Ethiopia
  • Somalia
West Africa
  • Nigeria
  • Ghana
  • Ivory Coast
  • Senegal
  • Mali
  • Guinea
  • Liberia
Southern Africa
  • South Africa
  • Zimbabwe
  • Zambia
  • Malawi
  • Mozambique
  • Botswana
  • Namibia

Asia

Southeast Asia
  • Thailand
  • Myanmar
  • Cambodia
  • Vietnam
  • Laos
  • Philippines
  • Indonesia
  • Malaysia
South Asia
  • India
  • Pakistan
  • Bangladesh
  • Sri Lanka
  • Nepal
  • Bhutan
  • Maldives

Americas

South America
  • Brazil
  • Peru
  • Bolivia
  • Colombia
  • Ecuador
  • Venezuela
  • Guyana
  • Suriname
Central America & Caribbean
  • Mexico
  • Guatemala
  • Honduras
  • Nicaragua
  • Costa Rica
  • Panama
  • Haiti
  • Dominican Republic

Pacific Islands

Melanesia
  • Papua New Guinea
  • Solomon Islands
  • Vanuatu
  • New Caledonia
  • Fiji
Other Pacific
  • Samoa
  • Tonga
  • Kiribati
  • Tuvalu
  • Marshall Islands

Registration Status

Regulatory Approvals

WHO Prequalification

Listed in WHO Prequalification of Medicines Programme (PQP)

Approved
US FDA

Approved under ANDA pathway for generic mefloquine

Approved
European Medicines Agency (EMA)

Approved through decentralized procedure

Approved
National Regulatory Authorities

Registered in over 50 countries worldwide

Multiple Approvals

Registration Process

1. Dossier Preparation

Complete CTD format dossier with all required documentation

2. Regulatory Submission

Submission to national regulatory authorities with local requirements

3. Review & Approval

Regulatory review process with timeline monitoring

4. Post-Approval Compliance

Ongoing compliance with pharmacovigilance and quality requirements

Available for Dossier Submission

Complete Registration Dossier

Comprehensive dossier available for registration in new markets:

  • Module 1: Administrative Information
  • Module 2: Quality Overall Summary
  • Module 3: Quality Documentation
  • Module 4: Non-clinical Studies
  • Module 5: Clinical Studies
Dossier Features:
  • CTD format compliant
  • eCTD ready for electronic submission
  • Country-specific adaptations available
  • Local language translations provided
  • Regulatory consultation support

Submission Support

Comprehensive support for dossier submission:

  • Regulatory strategy development
  • Country-specific requirement analysis
  • Submission timeline management
  • Regulatory authority liaison
  • Post-submission follow-up

Private Label & Contract Manufacturing

Contract Manufacturing Services

Available Services:
  • Private Label Manufacturing: Production under customer brand
  • Contract Manufacturing: Large-scale production for distributors
  • Technology Transfer: Complete process transfer capabilities
  • Custom Formulations: Tailored solutions for specific markets
Manufacturing Capabilities:
  • WHO-GMP certified facilities
  • Annual capacity: 500 million tablets
  • Multiple packaging options
  • Quality assurance at every stage
  • Regulatory compliance support

Partnership Opportunities

Partnership Models:
  • Distribution Partnerships: Exclusive and non-exclusive arrangements
  • Licensing Agreements: Technology and brand licensing
  • Joint Ventures: Strategic partnerships for market entry
  • Agency Agreements: Local representation and registration support
Partner Benefits:
  • Competitive pricing structure
  • Marketing and regulatory support
  • Training and technical assistance
  • Supply chain reliability
  • Quality assurance guarantee

Quality & Compliance Standards

Manufacturing Standards

  • WHO-GMP Certified Manufacturing Facility
  • ISO 9001:2015 Quality Management System
  • ISO 14001:2015 Environmental Management
  • OHSAS 18001:2007 Occupational Health & Safety
  • US FDA Current Good Manufacturing Practices (cGMP)
  • EU Good Manufacturing Practices

Quality Assurance

  • In-process quality controls
  • Finished product testing
  • Stability testing programs
  • Batch-to-batch consistency
  • Traceability systems
  • Continuous improvement programs

International Compliance

  • ICH Guidelines compliance
  • International Pharmacopeial standards
  • Country-specific regulatory requirements
  • Export quality certifications
  • Pharmacovigilance compliance
  • Environmental compliance